PVLA vs SEPN: stock comparison and AI forecast
Palvella Therapeutics, Inc. (PVLA) and Septerna, Inc. (SEPN) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
PVLA Palvella Therapeutics, Inc.
- Price
- $152.93 +18.1% · 6M
- Market Cap
- $2.34B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
SEPN Septerna, Inc.
- Price
- $47.88 +93.8% · 6M
- Market Cap
- $2.23B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- PVLA and SEPN have similar market capitalizations ($2.34B and $2.23B).
- Over the last six months SEPN returned +93.8% and PVLA +18.1%.
- SEPN carries 0.47 times debt per unit of equity, against 0.17 times for PVLA.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | PVLA | SEPN |
|---|---|---|
| Market Cap | $2.34B | $2.23B |
| P/B Ratio | 10.79x | 5.78x |
| EPS | $-5.57 | $-0.83 |
| Book Value/Share | $15.04 | $8.29 |
| Revenue/Share | – | $2.12 |
| FCF/Share | – | $2.25 |
Profitability & Margins
| Metric | PVLA | SEPN |
|---|---|---|
| ROE | -28.4% | -6.3% |
| ROA | -24.3% | -4.3% |
| ROIC | -23.9% | -8.9% |
| Operating Margin | – | -44.0% |
| Net Margin | – | -24.5% |
| EBT Margin | – | -23.2% |
| Tax Rate | 0.0% | -5.8% |
Financial Health
| Metric | PVLA | SEPN |
|---|---|---|
| Current Ratio | 21.18x | 4.99x |
| D/E Ratio | 0.17x | 0.47x |
| Financial Leverage | 1.17x | 1.47x |
| Interest Coverage | -24.0x | – |
| Working Capital | $241M | $317M |
Cash Flow
| Metric | PVLA | SEPN |
|---|---|---|
| Operating Cash Flow | -$37M | $106M |
| Free Cash Flow | – | $105M |
| Capital Spending | – | -$910K |
| FCF/Sales | – | 106.3% |
| CapEx/Sales | – | 0.9% |
Operational Efficiency
| Metric | PVLA | SEPN |
|---|---|---|
| Asset Turnover | – | 0.17x |
| Receivables Turnover | – | 8.1x |
| Fixed Assets Turnover | – | 25.4x |
| Days Sales Outstanding | – | 45 days |
Income Statement
| Metric | PVLA | SEPN |
|---|---|---|
| Total Revenue | – | $99M |
| Operating Income | -$58M | -$44M |
| Net Income | -$62M | -$24M |
| R&D Expense | $35M | $121M |
Dividend & Shareholder Information
| Metric | PVLA | SEPN |
|---|---|---|
| Shares Outstanding | 14M | 47M |
PVLA vs SEPN: stock comparison and AI forecast
Which is bigger, PVLA or SEPN?
PVLA and SEPN have similar market capitalizations ($2.34B and $2.23B).
Which stock performed better over the last six months, PVLA or SEPN?
Over the last six months SEPN returned +93.8% and PVLA +18.1%.
Which one does Intratio's AI model rank higher, PVLA or SEPN?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.